Plug Power Inc. $127 Million Common Stock Offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 46,000,000 shares of common stock of Plug Power Inc. for…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AbbVie Inc. $30 Billion Senior Notes Offering
Davis Polk advised the initial purchasers in connection with an unregistered offering by AbbVie Inc. of $30 billion aggregate principal amount of senior notes, consisting of (i) $750…
Davis Polk Advises MSCI Inc. on Its $500 Million Notes Offering Reopening
Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of an additional $500 million aggregate principal amount of its 4.000% senior notes due 2029. The…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…
Applied Therapeutics, Inc. Common Stock PIPE Offering
Davis Polk advised the placement agents in connection with a private placement of shares of common stock of Applied Therapeutics, Inc. The aggregate proceeds of the private placement…
Davis Polk Advises Centogene N.V. on Its Initial Public Offering
Davis Polk advised Centogene N.V. on its $56 million initial public offering of 4,000,000 of its common shares. In addition, Centogene has granted the underwriters a 30-day option to…
Davis Polk Advises MSCI Inc. on Its $500 Million Notes Offering
Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.000% senior notes due 2029. The notes are guaranteed by…
Davis Polk Advises BRP Group, Inc. on Its $229.6 Million Initial Public Offering
Davis Polk advised BRP Group, Inc. on its $229.6 million initial public offering of 16,400,000 shares of Class A common stock. The shares of Class A common stock are listed on the Nasdaq…
Davis Polk Advises Charles River Laboratories International, Inc. on Its $500 Million Notes Offering
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.250% senior notes…
Aprea Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…